The Brief Psychiatric Rating Scale (BPRS) is one of the oldest psychiatric measurement instruments still in active use. It was developed by John Overall and Donald Gorham in 1962, originally as a way to make psychiatric outcomes measurable in early antipsychotic trials. Six decades later it is still everywhere — in inpatient charts, in clinical trials, in textbook examples. This guide walks through what the BPRS actually measures, how to read its scores, and when it is the right choice versus more modern scales.
The BPRS is an 18-item, clinician-rated scale that measures the severity of common psychiatric symptoms — primarily psychosis, mood, and anxiety — in 20 to 30 minutes.
The 18 items
The original BPRS has 18 items, each rated on a 7-point severity scale (1 = not present, 7 = extremely severe). An expanded 24-item version exists for research purposes. The standard 18 items are:
- Somatic concern
- Anxiety
- Emotional withdrawal
- Conceptual disorganisation
- Guilt feelings
- Tension
- Mannerisms and posturing
- Grandiosity
- Depressive mood
- Hostility
- Suspiciousness
- Hallucinatory behaviour
- Motor retardation
- Uncooperativeness
- Unusual thought content
- Blunted affect
- Excitement
- Disorientation
The total score ranges from 18 (no symptoms) to 126 (maximum severity).
How it is administered
A clinician conducts a 20–30 minute interview and rates each item based on what the patient reports, what the clinician observes, and any collateral information. Some items are based primarily on observation (mannerisms and posturing, blunted affect, motor retardation), others on patient self-report (somatic concern, depressive mood, anxiety), and several on a combination of both.
How scores are interpreted
There is no universal cutoff for "schizophrenia" on the BPRS — it is a severity measure, not a diagnostic instrument. But several rough anchors are commonly cited:
- Total score < 31: minimal symptoms
- 31–40: mild illness
- 41–52: moderate illness
- > 52: marked or severe illness
A reduction of 20% in BPRS total score is often considered the minimum threshold for treatment response in clinical trials, with 50% sometimes used for "robust response."
Cluster scores
BPRS items are often grouped into clusters or factors. Different studies use slightly different groupings, but a common five-factor model includes:
- Positive symptoms: conceptual disorganisation, grandiosity, suspiciousness, hallucinatory behaviour, unusual thought content
- Negative symptoms: emotional withdrawal, motor retardation, blunted affect
- Affect: anxiety, guilt feelings, depressive mood
- Resistance: hostility, uncooperativeness, excitement
- Activation: tension, mannerisms and posturing, excitement
Cluster-level changes often tell you more than the total score. A drug might reduce positive symptoms substantially while leaving negative symptoms largely unchanged.
How the BPRS compares to the PANSS
The PANSS was developed in 1987 specifically to address gaps in the BPRS — particularly its under-coverage of negative symptoms. PANSS has 30 items, takes longer to administer, and produces three subscale scores in addition to a total. Many BPRS items appear, often essentially unchanged, in the PANSS.
In broad terms:
- BPRS is faster and easier to use clinically
- PANSS is more comprehensive, especially for negative symptoms
- BPRS has the longer historical record (1962 vs 1987)
- PANSS has become the standard for new drug development
- BPRS scores can be approximately translated to PANSS equivalents using published conversion tables
Where the BPRS is still useful
- Inpatient settings, where time is short and a quick severity measure is needed
- Long-term outcome studies that began before the PANSS existed, where consistency matters
- Training, because the smaller item set is easier to learn
- Mixed populations (schizophrenia plus mood or anxiety symptoms), where the broad coverage of the BPRS helps
- Tracking individual patients over time in routine clinical care
Where the BPRS is less useful
- For detailed assessment of negative symptoms — the BPRS only includes a few items in this domain
- For modern regulatory trials of new antipsychotics — the FDA generally expects PANSS
- For symptoms that have been recognised since 1962 (such as cognitive symptoms), which the original BPRS does not cover
Reliability and training
BPRS reliability between trained raters is generally good (intraclass correlations above 0.80 for total scores in well-trained groups). Reliability for individual items varies — observable items like motor retardation tend to be more reliable than inferred items like guilt feelings or emotional withdrawal. Most large trials require formal certification of raters before scoring counts.
What it looks like in your chart
If you see a BPRS score in your medical record, it usually appears as the total (for example, "BPRS total 38, mild illness, primarily positive cluster"). Some inpatient services use the BPRS at admission and repeat it weekly to track change. A drop of 5 to 10 points over a hospital stay is a typical magnitude for a successful inpatient course.
The bottom line
The BPRS is a workhorse — not glamorous, not modern, but reliable, fast, and broadly informative. It is the right tool for many clinical situations and the wrong tool for others. Understanding what it does and does not measure helps you read your own records and interpret the numbers you see in research with more confidence.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.